Doctors have begun clinical trials of an experimental vaccine for malaria in Burkina Faso and say they are encouraged by the initial results. The vaccine could become generally available within five years if it proves successful. Health Ministry officials said the MSP3 vaccine had been developed by the Pasteur Institute in France and was being tested on a group of 30 healthy people aged between 18 and 40.